Radical Numerics Launches With $50M Seed for Biology AI
Fundraise Insider tracks newly funded startups each week and delivers verified B2B leads list of C-suite contacts straight to your inbox, so you reach the right people while the funding is still fresh. See pricing.
Radical Numerics, an AI research company based in Menlo Park, California, has launched out of stealth with $50 million in a Seed round. The financing was led by Emergence Capital, with participation from First Spark Ventures, Obvious Ventures, Factory, and Triatomic Capital. Patrick Collison took part as a pre-seed investor.
The company sits at the intersection of artificial intelligence and biotechnology. It is building what it calls general biological intelligence, a new class of multimodal AI systems designed to reason across several layers of biology at once, spanning DNA, RNA, and proteins. The goal is to create models that can understand and design biological systems rather than just analyze them.
Radical Numerics previewed Omnii, its latest genomic language model. According to the company, early testing shows the model reaching state-of-the-art performance at identifying causal regulatory variants, and it can transfer knowledge across different biological applications without needing task-specific training, a sign that the underlying approach generalizes.
The company is already putting the technology to work through partnerships. It is collaborating with a cancer diagnostics company to explore applications in pancreatic and multi-cancer detection, using AI to analyze multiple molecular signals at the same time. It is also working with a national laboratory to develop systems that can identify and characterize pathogens, including ones that might be engineered using increasingly capable AI tools.
With $50 million behind it and a model already showing promise, Radical Numerics is entering a field where AI and biology are converging quickly, betting that systems able to reason across the full stack of biology will open up new ground in both medicine and biosecurity.